Essa. M. Saied | Pharmacology | Research Excellence Award

Assoc. Prof. Dr. Essa.M. Saied | Pharmacology | Research Excellence Award 

Associate Prof. Dr at Humboldt Universität zu Berlin | Germany

Assoc. Prof. Dr. Essa M. Saied is an accomplished scholar whose work spans pharmacology, bioorganic chemistry, and medicinal chemistry, contributing significantly to contemporary drug discovery and therapeutic innovation. His scholarly influence is demonstrated by 2,229 citations across 1,535 documents, 72 published works, and an h-index of 31, reflecting strong global recognition. Assoc. Prof. Dr. Essa M. Saied’s academic trajectory includes rigorous training in chemistry, culminating in advanced graduate studies with a specialization in organic and bioorganic chemistry, where he developed a solid foundation in molecular design, synthetic methodologies, and biochemical mechanisms. His professional journey includes progressive roles in academic and research institutions, where he has contributed to pioneering studies on small-molecule drug development, high-throughput screening, lipid biochemistry, heterocyclic chemistry, and the structural biology of disease-related enzymes. He has collaborated with multidisciplinary teams in developing chemical probes, enzymatic assays, and computational models, integrating experimental and in silico approaches to accelerate drug discovery pipelines. Assoc. Prof. Dr. Essa M. Saied’s research interests encompass synthetic medicinal chemistry, lipid metabolism, molecular modelling, virtual screening, anticancer agents, antiviral strategies, and the mechanistic understanding of bioactive metabolites in human disease. His publications in top-tier journals, including Nature, Angewandte Chemie, Nature Communications, PNAS, and Developmental Cell, highlight the depth and impact of his contributions. In addition to his research achievements, he has been actively involved in scientific reviewing, editorial roles, and mentorship, supporting the professional growth of emerging researchers and contributing to the quality and integrity of scientific publishing. His work bridges fundamental chemical sciences and applied biomedical research, enabling the translation of molecular insights into potential therapeutic strategies. Assoc. Prof. Dr. Essa M. Saied’s continuing efforts aim to expand the frontiers of pharmacological science through innovative chemical tools, mechanistic exploration of lipid pathways, and the development of novel drug candidates. In conclusion, Assoc. Prof. Dr. Essa M. Saied stands as a leading figure in his field, recognized for his impactful research, broad expertise, and sustained commitment to advancing scientific knowledge for global health benefit.

Profile: Scopus | Orcid | Google Scholar | Researchgate

Featured Publications:

1.Saied, E. M., et al. (2025). Synthesis and multi-target antiproliferative evaluation of novel 1,2,4-triazole-3-thione analogues against breast cancer: In silico and in vitro mechanistic insights. RSC Advances.

2.Saied, E. M., et al. (2025). Exploration of the anticancer efficacy of a novel 1,3-thiazole analog in an Ehrlich ascites carcinoma model: In vivo and in silico insights into hepatorenal protective potentials via modulation of apoptosis, oxidative stress and inflammation. RSC Advances.

3.Saied, E. M., et al. (2025). Mapping stress memory: Genetic and epigenetic insights into combined drought and heat tolerance in barley. Plant Cell Reports.

4.Saied, E. M., et al. (2025). Candidate gene discovery for the biofortification of wheat grains with essential micronutrients for global food security. Cereal Research Communications.

5.Saied, E. M., et al. (2025). Multi-targeted azacoumarin–cyanocinnamate hybrids induce G2/M arrest and apoptosis via tubulin and COX-2/VEGFR modulation: Insights from in vitro mechanistic basis and in vivo validation. RSC Medicinal Chemistry.

6.Saied, E. M., et al. (2025). Editorial: Medicinal chemistry for neglected tropical diseases using in vitro, in vivo, and in silico approaches. [Journal Name Not Provided].

7.Saied, E. M., et al. (2024). Live-cell identification of inhibitors of the lipid transfer protein CERT using nanoluciferase bioluminescence resonance energy transfer (NanoBRET). Angewandte Chemie International Edition.

Hammad Ullah | Pharmacology | Best Researcher Award

Dr.Hammad Ullah | Pharmacology | Best Researcher Award 

Assistant Professor at University of Management and Technology | Pakistan

Dr. Hammad Ullah is a highly accomplished researcher in pharmacology and food chemistry, renowned for his contributions to nutraceuticals, natural product research, and functional food development. He holds a Ph.D. in Nutraceuticals, Functional Foods, and Human Health from the University of Naples Federico II, Italy, conducted in collaboration with the University of Vigo, Spain, where his doctoral research focused on the bioactive potential of Prunus domestica L. in mitigating metabolic syndrome risk factors. His academic foundation is further supported by an M.Phil. in Pharmaceutical Sciences and a Doctor of Pharmacy degree, providing a strong interdisciplinary background bridging pharmacology, analytical chemistry, and human health. With professional experience as a postdoctoral researcher at the University of Naples Federico II, he has led and collaborated on numerous international research projects aimed at exploring the molecular mechanisms and therapeutic properties of natural bioactive compounds. His work encompasses the design and execution of preclinical and clinical studies, chromatographic and spectrophotometric analyses, and the development of nutraceuticals and food supplements with proven health benefits. Dr. Hammad Ullah has published 87 scientific documents, accumulating 2,870 citations across 2,698 scholarly works and achieving an h-index of 25, reflecting his significant impact and influence in the field. His research has been widely recognized through several prestigious honors, including the MEDWELL Award for Best Ph.D. Thesis, Dra. Mariola Macías Award from the Phytochemical Society of Europe, and the Young Research Award from MONASH INITIATE. Beyond his research, he serves as an editorial board member and guest editor for several high-impact journals such as Nutrients, Frontiers in Pharmacology, and BMC Complementary Medicine and Therapies, where he contributes to advancing scientific discourse in pharmacognosy, phytotherapy, and food science. His research interests lie in the discovery and biochemical characterization of polyphenols, phytonutrients, and natural antioxidants for disease prevention and metabolic regulation. Through his commitment to scientific excellence, mentorship, and international collaboration, Dr. Hammad Ullah continues to make influential contributions toward the advancement of pharmacological innovation and the integration of nutraceuticals into evidence-based healthcare solutions.

Profile: Scopus | Orcid | Google Scholar

Featured Publications:

  • Ullah, H., Dacrema, M., & Buccato, D. G. (2025). A narrative review on plant extracts for metabolic syndrome: efficacy, safety, and technological advances. Nutrients, 17(5), 877.

  • Ullah, H., Morone, M. V., Buccato, D. G., & Daglia, M. (2025). Efficacy and tolerability of a chemically characterized Scutellaria lateriflora L. extract-based food supplement for sleep management: A single-center, controlled, randomized, crossover, double-blind clinical trial. Nutrients.

  • Ullah, H., Dacrema, M., Uniyal, P., & Daglia, M. (2024). Baicalein as a potential bioactive flavonoid: a concise overview.

  • Ullah, H., Morone, M. V., de Lellis, L. F., Buccato, D. G., & Daglia, M. (2024). Efficacy of a food supplement based on monacolins, γ-oryzanol, and γ-aminobutyric acid in mild dyslipidemia: A randomized, double-blind, parallel-armed, placebo-controlled clinical trial. Nutrients.

  • Ullah, H., Esposito, C., Piccinocchi, R., & Daglia, M. (2022). Postprandial glycemic and insulinemic response by a brewer’s spent grain extract-based food supplement in subjects with slightly impaired glucose tolerance: A monocentric, randomized, cross-over, double-blind, placebo-controlled clinical trial. Nutrients.

  • Ullah, H., Khan, A., & Daglia, M. (2022). The focus on foods for special medical purposes and food supplements in age-related disorders.

  • Ullah, H., De Filippis, A., Santarcangelo, C., & Daglia, M. (2020). Epigenetic regulation by polyphenols in diabetes and related complications.